Drugs / AMG 333
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02132429 | May → Oct 2014 | migraine disorder | Amgen | Terminated | No outcome recorded |
| Phase 1 | NCT01953341 | Oct 2013 → Sep 2014 | migraine disorder | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 333 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01953341 ↗ |
| Route | Oral | “single oral dose of AMG 333” NCT01953341 ↗ |